Literatur
- 1
Alsheikh-Ali A A, Wang P J, Rand W. et al .
Enalapril treatment
and hospitalization with atrial tachyarrhythmias in patients with
left ventricular dysfunction.
Am Heart J.
2004;
147
1061-1065
- 2
Boldt A, Scholl A, Garbade J. et
al .
ACE-inhibitor treatment attenuates atrial structural
remodeling in patients with lone chronic atrial fibrillation.
Basic Res Cardiol.
2006;
101
261-267
- 3
Boldt L H, Rolf S, Huemer M. et
al .
Optimal heart failure therapy and successful cardioversion
in heart failure patients with atrial fibrillation.
Am
Heart J.
2008;
155
890-895
- 4
Brignole M, Gammage M, Puggioni E. et al .
Comparative assessment of right, left,
and biventricular pacing in patients with permanent atrial fibrillation.
Eur Heart J.
2005;
26
712-722
- 5
Cappato R, Calkins H, Chen S A. et al .
Worldwide survey on the methods, efficacy,
and safety of catheter ablation for human atrial fibrillation.
Circulation.
2005;
111
1100-1105
- 6
Cardin S, Li D, Thorin-Trescases N, Leung T K, Thorin E, Nattel S.
Evolution of the atrial
fibrillation substrate in experimental congestive heart failure:
angiotensin-dependent and -independent pathways.
Cardiovasc
Res.
2003;
60
315-325
- 7
Chang S L, Chen Y C, Chen Y J. et al .
Mechanoelectrical feedback
regulates the arrhythmogenic activity of pulmonary veins.
Heart.
2007;
93
82-88
- 8
Chen M S, Marrouche N F, Khaykin Y. et al .
Pulmonary vein isolation for the treatment
of atrial fibrillation in patients with impaired systolic function.
J Am Coll Cardiol.
2004;
43
1004-1009
- 9
Clark D M, Plumb V J, Epstein A E, Kay G N.
Hemodynamic
effects of an irregular sequence of ventricular cycle lengths during
atrial fibrillation.
JACC.
1997;
30
1039-1045
- 10
Cleland J G, Daubert J C, Erdmann E. et al .
The effect of cardiac resynchronization
on morbidity and mortality in heart failure.
N Engl J Med.
2005;
352
1539-1549
- 11
Corley S D, Epstein A E, DiMarco J P. et al .
Relationships between sinus rhythm,
treatment, and survival in the Atrial Fibrillation Follow-Up Investigation
of Rhythm Management (AFFIRM) Study.
Circulation.
2004;
109
1509-1513
- 12
Corradi D, Callegari S, Benussi S. et al .
Regional left atrial interstitial remodelling
in patients with chronic atrial fibrillation undergoing mitral-valve
surgery.
Virchows Arch.
2004;
445
498-505
- 13
Crijns H J, Tjeerdsma G, de Kam P J. et al .
Prognostic value of the presence and development
of atrial fibrillation in patients with advanced chronic heart failure.
Eur Heart J.
2000;
21
1238-1245
- 14
Doshi R N, Daoud E G, Fellows C. et al .
Left ventricular-based cardiac stimulation
post AV nodal ablation evaluation (the PAVE study).
J Cardiovasc
Electrophysiol.
2005;
16
1160-1165
- 15
Dries D L, Exner D V, Gersh B J. et al .
Atrial fibrillation is associated
with an increased risk for mortality and heart failure progression
in patients with asymptomatic and symptomatic left ventricular systolic dysfunction:
a retrospective analysis of the SOLVD Trials.
J Am Coll Cardiol.
1998;
32
695-703
- 16
Ducharme A, Swedberg K, Pfeffer M A. et al .
Prevention of atrial fibrillation in patients
with symptomatic chronic heart failure by candesartan in the Candesartan
in Heart failure: Assessment of Reduction in Mortality and morbidity
(CHARM) program.
Am Heart J.
2006;
152
86-92
- 17
Fuster V, Rydén L E, Cannom D S. et al .
ACC/AHA/ESC
2006 Guidelines for the Management of Patients with Atrial Fibrillation:
a report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines and the European
Society of Cardiology Committee for Practice Guidelines (Writing
Committee to Revise the 2001 Guidelines for the Management of Patients
With Atrial Fibrillation): developed in collaboration with the European
Heart Rhythm Association and the Heart Rhythm Society.
Circulation.
2006;
114
e257-e354
- 18
Gasparini M, Auricchio A, Regoli F. et al .
Four-year efficacy of cardiac resynchronization
therapy on exercise tolerance and disease progression: the importance
of performing atrioventricular junction ablation in patients with
atrial fibrillation.
J Am Coll Cardiol.
2006;
48
(4)
734-743
- 19
Gentlesk P J, Sauer W H, Gerstenfeld E P. et al .
Reversal of left ventricular dysfunction
following ablation of atrial fibrillation.
J Cardiovasc
Electrophysiol.
2007;
18
9-14
- 20
Goette A, Breithardt G, Fetsch T. et al .
Angiotensin II antagonist in paroxysmal
atrial fibrillation (ANTIPAF) trial: rationale and study design.
Clin Drug Investig.
2007;
27
697-705
- 21
Goette A, Staack T, Röcken C. et al .
Increased expression of extracellular signal-regulated
kinase and angiotensin-converting enzyme in human atria during atrial
fibrillation.
J Am Coll Cardiol.
2000;
35
1669-1677
- 22
Grönefeld G C, Mauss O, Li Y G, Klingenheben T, Hohnloser S H.
Association between atrial fibrillation
and appropriate implantable cardioverter defibrillator therapy:
results from a prospective study.
J Cardiovasc Electrophysiol.
2000;
11
1208-1214
- 23
Hanna N, Cardin S, Leung T K. et al .
Differences in atrial versus ventricular
remodeling in dogs with ventricular tachypacing-induced congestive
heart failure.
Cardiovasc Res.
2004;
63
236-244
- 24
Haverkamp W, Mönnig G, Schulze-Bahr E, Haverkamp F, Breithardt G.
Physician-induced torsade de pointes – therapeutic
implications.
Cardiovasc Drugs Ther.
2002;
16
101-109
- 25
Hsu L F, Jais P, Sanders P. et al .
Catheter ablation for atrial fibrillation in
congestive heart failure.
N Engl J Med.
2004;
351
2373-2383
- 26
Kuijpers N H, ten Eikelder H M, Bovendeerd P H, Verheule S, Arts T, Hilbers P A.
Mechanoelectric
feedback leads to conduction slowing and block in acutely dilated
atria: a modeling study of cardiac electromechanics.
Am
J Physiol Heart Circ Physiol.
2007;
292
H2832-2853
- 27
Leclercq C, Walker S, Linde C. et al .
Comparative effects of permanent biventricular
and right-univentricular pacing in heart failure patients with chronic
atrial fibrillation.
Eur Heart J.
2002;
22
1780-1787
- 28
Leon A R, Greenberg J M, Kanuru N. et al .
Cardiac resynchronization in patients with
congestive heart failure and chronic atrial fibrillation: effect
of upgrading to biventricular pacing after chronic right ventricular
pacing.
J Am Coll Cardiol.
2002;
39
1258-1263
- 29
Li D, Fareh S, Leung T K, Nattel S.
Promotion of atrial fibrillation
by heart failure in dogs: atrial remodelling of a different sort.
Circulation.
1999;
100
87-95
- 30
Madrid A H, Bueno M G, Rebollo J M. et al .
Use of irbesartan to maintain sinus
rhythm in patients with long-lasting persistent atrial fibrillation:
a prospective and randomized study.
Circulation.
2002;
106
331-336
- 31
Maggioni A P, Latini R, Carson P E. et al .
Valsartan reduces the incidence of atrial
fibrillation in patients with heart failure: results from the Valsartan
Heart Failure Trial (Val-HeFT).
Am Heart J.
2005;
149
548-557
- 32
Maisel W H, Stevenson L W.
Atrial fibrillation
in heart failure: epidemiology, pathophysiology, and rationale for
therapy.
Am J Cardiol.
2003;
91
2D-8D
- 33
Middlekauff H R, Stevenson W G, Stevenson L W.
Prognostic significance of atrial
fibrillation in advanced heart failure: a study of 390 patients.
Circulation.
1991;
84
40-48
- 34
Nasr I A, Bouzamondo A, Hulot J S, Dubourg O, Le H euzey
JY, Lechat P.
Prevention
of atrial fibrillation onset by beta-blocker treatment in heart
failure: a meta-analysis.
Eur Heart J.
2007;
28
457-462
- 35
Pasic M, Bergs P, Müller P. et al .
Intraoperative radiofrequency maze ablation
for atrial fibrillation: the Berlin modification.
Ann
Thorac Surg.
2001;
72
1484-1490
- 36
Pedersen O D, Abildstrøm S Z, Ottesen M M. et al .
Increased risk
of sudden and non-sudden cardiovascular death in patients with atrial
fibrillation/flutter following acute myocardial infarction.
Eur Heart J.
2006;
27
290-295
- 37
Pedersen O D, Bagger H, Kober L, Torp-Pedersen C.
Trandolapril reduces
the incidence of atrial fibrillation after acute myocardial infarction
in patients with left ventricular dysfunction.
Circulation.
1999;
100
376-380
- 38
Pedersen O D, Søndergaard P, Nielsen T. et al .
Atrial fibrillation, ischaemic
heart disease, and the risk of death in patients with heart failure.
Eur Heart J.
2006;
27
2866-2870
- 39
Rathore S S, Curtis J P, Wang Y, Bristow M R, Krumholz H M.
Association of serum digoxin concentration
and outcomes in patients with heart failure.
JAMA.
2003;
289
871-878
- 40
Rienstra M, Smit M D, Nieuwland W. et al .
Persistent atrial fibrillation is associated
with appropriate shocks and heart failure in patients with left
ventricular dysfunction treated with an implantable cardioverter
defibrillator.
Am Heart J.
2007;
153
120-126
- 41
Roy D, Talajic M, Nattel S. et
al .
Atrial Fibrillation and Congestive Heart Failure
Investigators. Rhythm control versus rate control for atrial fibrillation
and heart failure.
N Engl J Med.
2008;
358
2667-2677
- 42
Ryan S, Siemon G, Drögemüller A. et al .
2 year follow-up of 321
patients with an implantable cardioverter/defibrillator:
comparison of patients with and without atrial fibrillation.
Z
Kardiol.
2001;
90
906-915
- 43
Shi Y, Li D, Tardif J C, Nattel S.
Enalapril effects on
atrial remodeling and atrial fibrillation in experimental congestive
heart failure.
Cardiovasc Res.
2002;
54
456-461
- 44
Sie H T, Beukema W P, Elvan A, Ramdat M isier AR.
Long-term
results of irrigated radiofrequency modified maze procedure in 200
patients with concomitant cardiac surgery: six years experience.
Ann Thorac Surg.
2004;
77
512-516
- 45
Swedberg K, Olsson L G, Charlesworth A. et al .
Prognostic relevance of atrial
fibrillation in patients with chronic heart failure on long-term treatment
with beta-blockers: results from COMET.
Eur Heart J.
2005;
26
1303-1308
- 46
Sweeney M O, Hellkamp A S, Ellenbogen K A. et al .
Adverse effect
of ventricular pacing on heart failure and atrial fibrillation among
patients with normal baseline QRS duration in a clinical trial of
pacemaker therapy for sinus node dysfunction.
Circulation.
2003;
107
2932-2937
- 47
Ueng K C, Tsai T P, Yu W C. et al .
Use of enalapril to facilitate sinus rhythm
maintenance after external cardioversion of long-standing persistent
atrial fibrillation. Results of a prospective and controlled study.
Eur Heart J.
2003;
24
2090-2098
- 48
Van Gelder I C, Hagens V E, Bosker H A. et al, Rate Control versus Electrical Cardioversion
for Persistent Atrial Fibrillation Study Group .
A comparison
of rate control and rhythm control in patients with recurrent persistent
atrial fibrillation.
N Engl J Med.
2002;
347
1834-1840
- 49
Vermes E, Tardif J C, Bourassa M G. et al .
Enalapril decreases the
incidence of atrial fibrillation in patients with left ventricular
dysfunction: insight from the Studies Of Left Ventricular Dysfunction
(SOLVD) trials.
Circulation.
2003;
107
2926-2931
- 50
Wyse D G, Waldo A L, DiMarco J P. et al, Atrial Fibrillation Follow-up Investigation
of Rhythm Management (AFFIRM) Investigators .
Comparison
of rate control and rhythm control in patients with atrial fibrillation.
N Eng J Med.
2002;
347
1825-1833
Dr. med. Leif-Hendrik Boldt
Medizinische Klinik mit Schwerpunkt Kardiologie, Charité – Universitätsmedizin
Berlin, Campus Virchow Klinikum
Augustenburger
Platz 1
13353 Berlin
eMail: leif-hendrik.boldt@charite.de
